1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 8
1.2 Research Methodology 11
1.2.1 Overview of Market Research Methodology 11
1.2.2 Market Assumption 12
1.2.3 Secondary Data 12
1.2.4 Primary Data 12
1.2.5 Data Filtration and Model Design 13
1.2.6 Market Size/Share Estimation 14
1.2.7 Research Limitations 15
1.3 Executive Summary 16
2 Market Overview and Dynamics 19
2.1 Market Size and Forecast 19
2.1.1 Impact of COVID-19 on World Economy 20
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 32
2.4 Emerging Opportunities and Market Trends 35
2.5 Porters Fiver Forces Analysis 39
3 Segmentation of Asia Pacific Market by Drug Type 43
3.1 Market Overview by Drug Type 43
3.2 Small Molecule Drugs 45
3.3 Biologic Drugs 46
4 Segmentation of Asia Pacific Market by Service 47
4.1 Market Overview by Service 47
4.2 Medicinal Chemical Services 49
4.3 Biological Services 50
4.4 Drug Metabolism and Pharmacokinetics (DMPK) Services 51
4.5 Other Pharmaceutical Services 52
5 Segmentation of Asia Pacific Market by Process 53
5.1 Market Overview by Process 53
5.2 Target Selection 55
5.3 Target Validation 56
5.4 Hit-To-Lead Identification 57
5.5 Lead Optimization 58
5.6 Candidate Validation 59
6 Segmentation of Asia Pacific Market by Technology 60
6.1 Market Overview by Technology 60
6.2 High Throughput Screening 62
6.3 Combinatorial Chemistry 63
6.4 Pharmacogenomics and Pharmacogenetics 64
6.5 Nanotechnology 65
6.6 Bioanalytical Instruments 66
6.7 Biochips 67
6.8 Bioinformatics 68
6.9 Other Technologies 69
7 Segmentation of Asia Pacific Market by Therapeutic Area 70
7.1 Market Overview by Therapeutic Area 70
7.2 Oncology 72
7.3 Neurology 73
7.4 Infectious and Immune System Diseases 74
7.5 Digestive System Diseases 75
7.6 Cardiovascular Diseases 76
7.7 Diabetes 77
7.8 Respiratory Disease 78
7.9 Other Therapeutic Areas 79
8 Segmentation of Asia Pacific Market by End User 80
8.1 Market Overview by End User 80
8.2 Pharmaceutical Companies 82
8.3 Contract Research Organizations (CROs) 83
8.4 Research Institutes 84
8.5 Other End Users 85
9 Asia-Pacific Market 2019-2030 by Country 86
9.1 Overview of Asia-Pacific Market 86
9.2 Japan 89
9.3 China 92
9.4 Australia 94
9.5 India 96
9.6 South Korea 98
9.7 Rest of APAC Region 100
10 Competitive Landscape 102
10.1 Overview of Key Vendors 102
10.2 New Product Launch, Partnership, Investment, and M&A 105
10.3 Company Profiles 106
Abbott Laboratories Inc. 106
Agilent Technologies Inc. 108
Astrazeneca plc 109
Bayer AG 110
Charles River Laboratories International Inc. 111
Eli Lilly and Company 112
F. Hoffmann-La Roche Ltd 113
GlaxoSmithKline PLC 114
Merck & Co. Inc. 115
Novartis AG 116
Pfizer Inc. 117
Shimadzu Corp 118
Thermo Fisher Scientific Inc. 119
RELATED REPORTS 120